| Bioactivity | AUNP-12 (NP-12) is a peptide antagonist of the PD-1 signaling pathway, displays equipotent antagonism toward PD-L1 and PD-L2 in rescue of lymphocyte proliferation and effector functions. AUNP-12 exhibits immune activation, excellent antitumor activity, and potential for better management of immune-related adverse events (irAEs)[1]. | ||||||
| Invitro | AUNP-12 displays equipotent antagonism toward PD-L1 and PD-L2 in rescue of lymphocyte proliferation and effector functions [1].AUNP-12 rescues the proliferation in the mouse splenocyte assay system, with average EC50 values of 17 nM and 16.6 nM against rmPD-L1 and rmPD-L2 respectively[1].AUNP-12 is also able to significantly rescue recombinant human PD-L1 and PD-L2 mediated inhibition of in vitro human PBMC proliferation, with average EC50 values of 63.3 nM and 44.1 nM against PD-L1 and PD-L2 respectively[1]. | ||||||
| Name | AUNP-12 | ||||||
| CAS | 1353563-85-5 | ||||||
| Shortening | H-SNTSESFKF(H-SNTSESF)RVTQLAPKAQIKE-NH2 | ||||||
| Formula | C142H226N40O48 | ||||||
| Molar Mass | 3261.55 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
AUNP-12
CAS: 1353563-85-5 F: C142H226N40O48 W: 3261.55
AUNP-12 (NP-12) is a peptide antagonist of the PD-1 signaling pathway, displays equipotent antagonism toward PD-L1 and P
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.